Chemotherapy-induced nausea and vomiting: roles of pharmacists and formulary decision makers

Despite guidelines and medications available for the management of chemotherapy-induced nausea and vomiting (CINV), many patients with cancer are persistently affected by this dreadful adverse effect. It is not only physically and mentally draining, but financially strenuous as well. Along with these concerns, health-related consequences as dehydration, epigastric pain, and anorexia can arise. Therefore, compliance becomes a big issue in this patient population. It is important for healthcare professionals to educate patients and incorporate strategies by not only addressing but also individualizing treatment regimens and determining risk factors for potential CINV. By making formulary considerations using patient-centered and evidence-based treatment, patient outcomes can improve. Overall, it is necessary to understand the impact of CINV on quality of life and addressing it actively can significantly enhance care of patients with cancer.